The Exchange had sought clarification from Dr Reddys Laboratories with respect to news article appearing in Mint on September 4, 2015 titled ‘Dr Reddys looks to move beyond drugs with VC arm’. Dr Reddys Laboratories replied stating that in this regard, please note that the article clearly states that we are still evaluating and considering proposal on this front. It being still in an evaluation stage and hence there is nothing to report by way of any impact on company’s revenues.
The above information is a part of company’s filings submitted to BSE.
